JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405602200 on September 3, 2004

J. Biol. Chem., Vol. 279, Issue 47, 49099-49104, November 19, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/47/49099    most recent
M405602200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.-H.
Right arrow Articles by Miller, C. C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-H.
Right arrow Articles by Miller, C. C. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Neuronal Adaptor Protein X11{beta} Reduces Amyloid {beta}-Protein Levels and Amyloid Plaque Formation in the Brains of Transgenic Mice*

Ju-Hyun Lee{ddagger}, Kwok-Fai Lau{ddagger}, Michael S. Perkinton, Claire L. Standen, Boris Rogelj, Agnieszka Falinska, Declan M. McLoughlin, and Christopher C. J. Miller§

From the Department of Neuroscience and Section of Old Age Psychiatry, The Institute of Psychiatry, King's College London SE5 8AF, United Kingdom

Accumulation of cerebral amyloid {beta}-protein (A{beta}) is believed to be part of the pathogenic process in Alzheimer's disease. A{beta} is derived by proteolytic cleavage from a precursor protein, the amyloid precursor protein (APP). APP is a type-1 membrane-spanning protein, and its carboxyl-terminal intracellular domain binds to X11{beta}, a neuronal adaptor protein. X11{beta} has been shown to inhibit the production of A{beta} in transfected non-neuronal cells in culture. However, whether this is also the case in vivo in the brain and whether X11{beta} can also inhibit the deposition of A{beta} as amyloid plaques is not known. Here we show that transgenic overexpression of X11{beta} in neurons leads to a decrease in cerebral A{beta} levels in transgenic APPswe Tg2576 mice that are a model of the amyloid pathology of Alzheimer's disease. Moreover, overexpression of X11{beta} retards amyloid plaque formation in these APPswe mice. Our findings suggest that modulation of X11{beta} function may represent a novel therapeutic approach for preventing the amyloid pathology of Alzheimer's disease.


Received for publication, May 19, 2004 , and in revised form, September 1, 2004.

* This work was supported by grants from the Medical Research Council, Wellcome Trust, European Union Fifth Framework, Research into Aging, The Health Foundation, and the Alzheimer's Disease Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Both authors contributed equally to this work.

§ To whom correspondence should be addressed: Dept. of Neuroscience, P. O. Box P037, The Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. Tel.: 44-207-8480393; Fax: 44-207-7080017; E-mail: chris.miller{at}iop.kcl.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Sano, A. Syuzo-Takabatake, T. Nakaya, Y. Saito, S. Tomita, S. Itohara, and T. Suzuki
Enhanced Amyloidogenic Metabolism of the Amyloid beta-Protein Precursor in the X11L-deficient Mouse Brain
J. Biol. Chem., December 8, 2006; 281(49): 37853 - 37860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-S. Hoe, T. S. Tran, Y. Matsuoka, B. W. Howell, and G. W. Rebeck
DAB1 and Reelin Effects on Amyloid Precursor Protein and ApoE Receptor 2 Trafficking and Processing
J. Biol. Chem., November 17, 2006; 281(46): 35176 - 35185.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Suzuki, Y. Araki, T. Yamamoto, and T. Nakaya
Trafficking of Alzheimer's Disease-Related Membrane Proteins and Its Participation in Disease Pathogenesis
J. Biochem., June 1, 2006; 139(6): 949 - 955.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Neumann, S. Schobel, S. Jager, A. Trautwein, C. Haass, C. U. Pietrzik, and S. F. Lichtenthaler
Amyloid Precursor-like Protein 1 Influences Endocytosis and Proteolytic Processing of the Amyloid Precursor Protein
J. Biol. Chem., March 17, 2006; 281(11): 7583 - 7594.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Tudor, M. S. Perkinton, A. Schmidt, S. Ackerley, J. Brownlees, N. J. O. Jacobsen, H. L. Byers, M. Ward, A. Hall, P. N. Leigh, et al.
ALS2/Alsin Regulates Rac-PAK Signaling and Neurite Outgrowth
J. Biol. Chem., October 14, 2005; 280(41): 34735 - 34740.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.